{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:47Z","timestamp":1782722747225,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xkme.2026.101405","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:37:17Z","timestamp":1778765837000},"page":"101405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["When Atypical Becomes Typical: A Fulminant Seronegative Anti-GBM Disease"],"prefix":"10.1016","volume":"8","author":[{"given":"Faten Y.","family":"Andrawes-Barbara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Jiries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Vdovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Ben-Izhak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etty","family":"Kruzel-Davila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.xkme.2026.101405_bib1","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.01380217","article-title":"Anti-glomerular basement membrane disease","volume":"12","author":"McAdoo","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2026.101405_bib2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.kint.2016.02.001","article-title":"The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis","volume":"89","author":"Nasr","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.xkme.2026.101405_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/jclinpath-2018-205278","article-title":"Clinicopathological features and outcome of antibody-negative anti-glomerular basement membrane disease","volume":"72","author":"Liang","year":"2019","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.xkme.2026.101405_bib4","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3389\/fimmu.2020.02035","article-title":"Clinical-pathological features and outcome of atypical anti-glomerular basement membrane disease in a large single cohort","volume":"11","author":"Shen","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.xkme.2026.101405_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2023.11.003","article-title":"Atypical anti-glomerular Basement Membrane Nephritis: A Case Series from the French Nephropathology Group","volume":"83","author":"Chauveau","year":"2024","journal-title":"Am J Kidney Dis Atypi"},{"issue":"2","key":"10.1016\/j.xkme.2026.101405_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clim.2009.07.005","article-title":"The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease","volume":"133","author":"Yang","year":"2009","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.xkme.2026.101405_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MAJ.0b013e31818fff94","article-title":"Landmark publication from the American Journal of the Medical Sciences: the significance of certain pulmonary lesions in relation to the etiology of influenza","volume":"338","author":"Goodpasture","year":"2009","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.xkme.2026.101405_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ki.1973.14","article-title":"Anti-glomerular basement membrane antibody-induced glomerulonephritis","volume":"3","author":"Wilson","year":"1973","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.xkme.2026.101405_bib9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ekir.2023.03.010","article-title":"Atypical anti-glomerular Basement Membrane Disease","volume":"8","author":"Bharati","year":"2023","journal-title":"Kidney Int Rep. Atypi"},{"issue":"2","key":"10.1016\/j.xkme.2026.101405_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ajkd.2013.08.032","article-title":"Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease","volume":"63","author":"Ohlsson","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2026.101405_bib11","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.4049\/jimmunol.1202204","article-title":"Proteolysis breaks tolerance toward intact alpha345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for alpha345NC1 hexamers","volume":"190","author":"Olaru","year":"2013","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.xkme.2026.101405_bib12","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1053\/ajkd.2002.33385","article-title":"Goodpasture\u2019s disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques","volume":"39","author":"Salama","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2026.101405_bib13","first-page":"16","article-title":"Atypical anti-glomerular basement membrane disease with diffuse crescentic membranoproliferative glomerulonephritis: Case report and review of literature","volume":"2020","author":"Elshirbeny","year":"2020","journal-title":"Qatar Med J. Atypi"},{"issue":"5","key":"10.1016\/j.xkme.2026.101405_bib14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/ckj\/sfw068","article-title":"Atypical anti-glomerular basement membrane disease: lessons learned","volume":"9","author":"Glassock","year":"2016","journal-title":"Clin Kidney J. Atypi"},{"issue":"1","key":"10.1016\/j.xkme.2026.101405_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ndt\/gfaf211","article-title":"The multiple autoantibodies in anti-GBM disease","volume":"41","author":"Prendecki","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.xkme.2026.101405_bib16","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1111\/j.1600-6143.2006.01502.x","article-title":"Recurrent glomerulonephritis after kidney transplantation","volume":"6","author":"Choy","year":"2006","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.xkme.2026.101405_bib17","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/ndt\/gfq115","article-title":"Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes","volume":"25","author":"Yang","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2026.101405_bib18","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.kint.2019.06.019","article-title":"The IgG-degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti-glomerular basement membrane antibodies in patients with refractory anti-glomerular basement membrane disease","volume":"96","author":"Soveri","year":"2019","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.xkme.2026.101405_bib19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1681\/ASN.2021111460","article-title":"Endopeptidase cleavage of anti-glomerular basement membrane antibodies in vivo in severe kidney disease: an open-label Phase 2a study","volume":"33","author":"Uhlin","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2026.101405_bib20","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.kint.2016.01.018","article-title":"Glomerular disease with idiopathic linear immunoglobulin deposition: a rose by any other name would be atypical","volume":"89","author":"Rosales","year":"2016","journal-title":"Kidney Int"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:09:00Z","timestamp":1782720540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526001676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2590059526001676"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101405","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When Atypical Becomes Typical: A Fulminant Seronegative Anti-GBM Disease","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101405"}}